These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34246677)

  • 21. The efficacy of antivenom in loxoscelism treatment.
    Pauli I; Puka J; Gubert IC; Minozzo JC
    Toxicon; 2006 Aug; 48(2):123-37. PubMed ID: 16808942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LALLT (Loxosceles Allergen-Like Toxin) from the venom of Loxosceles intermedia: Recombinant expression in insect cells and characterization as a molecule with allergenic properties.
    Justa HCD; Matsubara FH; de-Bona E; Schemczssen-Graeff Z; Polli NLC; de Mari TL; Boia-Ferreira M; Minozzo JC; Wille ACM; Senff-Ribeiro A; Gremski LH; Veiga SS
    Int J Biol Macromol; 2020 Dec; 164():3984-3999. PubMed ID: 32871121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
    Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
    Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
    Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brown spiders and loxoscelism.
    da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
    Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
    da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial characterization of Loxosceles anomala (Mello-Leitão, 1917) venom: A brown spider of potential medical concern.
    Peres-Damásio P; Silva-Magalhães R; Silva-Araújo AL; Pereira EHT; Silveira AL; Varella LSDRN; Borges MH; Chavez-Olórtegui C; Paiva ALB; Guerra-Duarte C
    Toxicon; 2023 Jun; 228():107107. PubMed ID: 37011787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel ICK peptide from the Loxosceles intermedia (brown spider) venom gland: cloning, heterologous expression and immunological cross-reactivity approaches.
    Matsubara FH; Gremski LH; Meissner GO; Constantino Lopes ES; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS
    Toxicon; 2013 Sep; 71():147-58. PubMed ID: 23751278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Web of Coagulotoxicity: Failure of Antivenom to Neutralize the Destructive (Non-Clotting) Fibrinogenolytic Activity of
    Grashof D; Zdenek CN; Dobson JS; Youngman NJ; Coimbra F; Benard-Valle M; Alagon A; Fry BG
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 32019058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cloning and functional characterization of recombinant Loxtox from Loxosceles similis venom.
    Leal HG; de Oliveira Mendes BBR; Horta CCR; Pereira NB; Ferreira DSM; da Silva TS; Biscoto GL; Kalapothakis Y; Machado de Avila RA; Chávez-Olórtegui C; Kalapothakis E
    Int J Biol Macromol; 2020 Dec; 164():1112-1123. PubMed ID: 32702423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms.
    Toro AF; Malta MB; Soares SL; Da Rocha GC; da Silva Lira M; De Oliveira TA; Takehara HA; Lopes-Ferreira M; Santoro ML; Guidolin R; Gondo Higashi H; Fernandes I; Barbaro KC
    Toxicon; 2006 Nov; 48(6):649-61. PubMed ID: 16979205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia.
    Braz A; Minozzo J; Abreu JC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 1999 Sep; 37(9):1323-8. PubMed ID: 10400292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
    Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
    Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom.
    Kalapothakis E; Araujo SC; de Castro CS; Mendes TM; Gomez MV; Mangili OC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 2002 Dec; 40(12):1691-9. PubMed ID: 12457881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of astacin-like metalloproteases identified by transcriptomic analysis in Peruvian Loxosceles laeta spider venom and in vitro activity characterization.
    Medina-Santos R; Guerra-Duarte C; de Almeida Lima S; Costal-Oliveira F; Alves de Aquino P; Oliveira do Carmo A; Ferreyra CB; Gonzalez-Kozlova EE; Kalapothakis E; Chávez-Olórtegui C
    Biochimie; 2019 Dec; 167():81-92. PubMed ID: 31476328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From taxonomy to molecular characterization of brown spider venom: An overview focused on Loxosceles similis.
    Oliveira-Mendes BBR; Chatzaki M; Sales-Medina DF; Leal HG; van der Veer R; Biscoto GL; Gonçalves PM; Soares da Silva T; Guerra-Duarte C; Kalapothakis E; Horta CCR
    Toxicon; 2020 Jan; 173():5-19. PubMed ID: 31726080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.